We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01932554
Recruitment Status : Withdrawn (Insufficient recruitment)
First Posted : August 30, 2013
Last Update Posted : March 26, 2015
Janssen Services, LLC
Information provided by (Responsible Party):
William Ferguson M.D., St. Louis University

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : March 2015
Actual Study Completion Date : March 2015